Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension

Emerging evidences indicate that diminished activity of the vasoprotective axis of the renin–angiotensin system, constituting angiotensin-converting enzyme 2 (ACE2) and its enzymatic product, angiotensin-(1-7) [Ang-(1-7)] contribute to the pathogenesis of pulmonary hypertension (PH). However, long-term repetitive delivery of ACE2 or Ang-(1-7) would require enhanced protein stability and ease of administration to improve patient compliance. Chloroplast expression of therapeutic proteins enables their bioencapsulation within plant cells to protect against gastric enzymatic degradation and facilitates long-term storage at room temperature. Besides, fusion to a transmucosal carrier helps effective systemic absorption from the intestine on oral delivery. We hypothesized that bioencapsulating ACE2 or Ang-(1-7) fused to the cholera nontoxin B subunit would enable development of an oral delivery system that is effective in treating PH. PH was induced in male Sprague Dawley rats by monocrotaline administration. Subset of animals was simultaneously treated with bioencapsulaed ACE2 or Ang-(1-7) (prevention protocol). In a separate set of experiments, drug treatment was initiated after 2 weeks of PH induction (reversal protocol). Oral feeding of rats with bioencapsulated ACE2 or Ang-(1-7) prevented the development of monocrotaline-induced PH and improved associated cardiopulmonary pathophysiology. Furthermore, in the reversal protocol, oral ACE2 or Ang-(1-7) treatment significantly arrested disease progression, along with improvement in right heart function, and decrease in pulmonary vessel wall thickness. In addition, a combination therapy with ACE2 and Ang-(1-7) augmented the beneficial effects against monocrotaline-induced lung injury. Our study provides proof-of-concept for a novel low-cost oral ACE2 or Ang-(1-7) delivery system using transplastomic technology for pulmonary disease therapeutics

Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension

Emerging evidences indicate that diminished activity of the vasoprotective axis of the renin–angiotensin system, constituting angiotensin-converting enzyme 2 (ACE2) and its enzymatic product, angiotensin-(1-7) [Ang-(1-7)] contribute to the pathogenesis of pulmonary hypertension (PH). However, long-term repetitive delivery of ACE2 or Ang-(1-7) would require enhanced protein stability and ease of administration to improve patient compliance. Chloroplast expression of therapeutic proteins enables their bioencapsulation within plant cells to protect against gastric enzymatic degradation and facilitates long-term storage at room temperature. Besides, fusion to a transmucosal carrier helps effective systemic absorption from the intestine on oral delivery. We hypothesized that bioencapsulating ACE2 or Ang-(1-7) fused to the cholera nontoxin B subunit would enable development of an oral delivery system that is effective in treating PH. PH was induced in male Sprague Dawley rats by monocrotaline administration. Subset of animals was simultaneously treated with bioencapsulaed ACE2 or Ang-(1-7) (prevention protocol). In a separate set of experiments, drug treatment was initiated after 2 weeks of PH induction (reversal protocol). Oral feeding of rats with bioencapsulated ACE2 or Ang-(1-7) prevented the development of monocrotaline-induced PH and improved associated cardiopulmonary pathophysiology. Furthermore, in the reversal protocol, oral ACE2 or Ang-(1-7) treatment significantly arrested disease progression, along with improvement in right heart function, and decrease in pulmonary vessel wall thickness. In addition, a combination therapy with ACE2 and Ang-(1-7) augmented the beneficial effects against monocrotaline-induced lung injury. Our study provides proof-of-concept for a novel low-cost oral ACE2 or Ang-(1-7) delivery system using transplastomic technology for pulmonary disease therapeutics

Experimental investigation on an integrated thermal management system with heat pipe heat exchanger for electric vehicle

An integrated thermal management system combining a heat pipe battery cooling/preheating system with the heat pump air conditioning system is presented to fulfill the comprehensive energy utilization for electric vehicles. A test bench with battery heat pipe heat exchanger and heat pump air conditioning for a regular five-chair electric car is set up to research the performance of this integrated system under different working conditions. The investigation results show that as the system is designed to meet the basic cabinet cooling demand, the additional parallel branch of battery chiller is a good way to solve the battery group cooling problem, which can supply about 20% additional cooling capacity without input power increase. Its coefficient of performance for cabinet heating is around 1.34 at −20 °C out-car temperature and 20 °C in-car temperature. The specific heat of the battery group is tested about 1.24 kJ/kg °C. There exists a necessary temperature condition for the heat pipe heat exchanger to start action. The heat pipe heat transfer performance is around 0.87 W/°C on cooling mode and 1.11 W/°C on preheating mode. The gravity role makes the heat transfer performance of the heat pipe on preheating mode better than that on cooling mode

Sensitive Detection of Haloperidol and Hydroxyzine at Multi-Walled Carbon Nanotubes-Modified Glassy Carbon Electrodes

Haloperidol (i.e. HPD) and hydroxyzine (i.e. HXY), two effective and important tranquilizers with low redox activity, were found to generate an irreversible anodic peak at about +0.86 V (vs. SCE) or two anodic peaks at about +0.83 and +0.91 V in 0.05 M NaH2PO4-Na2HPO4 (pH=7.0) buffer solution with a multi-walled carbon nanotubes-modified glassy carbon electrode (i.e. MWNTs/GC), respectively. Their sensitive and quantitative measurement based on the first two anodic peaks was established under the optimum conditions. The anodic peak current was linear to HPD and HXY concentration from 1×10-7 to 2.5 ×10-5 M and 5×10-8 to 2.5 ×10-5 M, the detection limits obtained were 8×10-9 and 5×10-9 M, separately. The modified electrode exhibited some excellent characteristics including easy regeneration, high stability, good reproducibility and selectivity. The method proposed was successfully applied to the detection of HPD and HXY in drug tablets and proved to be reliable compared with ultraviolet spectrophotometry. The modified electrode was characterized by electrochemical methods

Effect of high pressure sintering and annealing on microstructure and thermoelectric properties of nanocrystalline Bi2Te2.7Se0.3 doped with Gd

Bi2Te2.7Se0.3 of high performance doped with Gd bulk materials was prepared by a high pressure (6.0 GPa) sintering (HPS) method at 593 K, 633 K, 673 K and 693 K. The sample was then annealed for 36 h in a vacuum at 633 K. The phase composition, crystal structure and morphology of the sample were analyzed by X-ray diffraction and scanning electron microscopy. The electric conductivity, Seebeck coefficient, and thermal conductivity aspects of the sample were measured from 298 K to 473 K. The results show that high pressure sintering and the doping with Gd has a great effect on the crystal structure and the thermoelectric properties of the samples. The samples are consisted of nanoparticles before and after annealing, and these nanostructures have good stability at high temperature. HPS together with annealing can improve the TE properties of the sample by decreasing the thermal conductivity of the sample with nanostructures. The maximum ZT value of 0.74 was obtained at 423 K for the sample, which was sintered at 673 K and then annealed at 633 K for 36 h. Compared with the zone melting sample, it was increased by 85% at 423 K. Hence the temperature of the maximum of figure of merit was increased. The results can be applied to the field of thermoelectric power generation materials

Research Progress and Reaction Mechanism of CO₂ Methanation over Ni-Based Catalysts at Low Temperature: A Review

The combustion of fossil fuels has led to a large amount of carbon dioxide emissions and increased greenhouse effect. Methanation of carbon dioxide can not only mitigate the greenhouse effect, but also utilize the hydrogen generated by renewable electricity such as wind, solar, tidal energy, and others, which could ameliorate the energy crisis to some extent. Highly efficient catalysts and processes are important to make CO2 methanation practical. Although noble metal catalysts exhibit higher catalytic activity and CH4 selectivity at low temperature, their large-scale industrial applications are limited by the high costs. Ni-based catalysts have attracted extensive attention due to their high activity, low cost, and abundance. At the same time, it is of great importance to study the mechanism of CO2 methanation on Ni-based catalysts in designing high-activity and stability catalysts. Herein, the present review focused on the recent progress of CO2 methanation and the key parameters of catalysts including the essential nature of nickel active sites, supports, promoters, and preparation methods, and elucidated the reaction mechanism on Ni-based catalysts. The design and preparation of catalysts with high activity and stability at low temperature as well as the investigation of the reaction mechanism are important areas that deserve further study

Research Progress and Reaction Mechanism of CO2 Methanation over Ni-Based Catalysts at Low Temperature: A Review

The combustion of fossil fuels has led to a large amount of carbon dioxide emissions and increased greenhouse effect. Methanation of carbon dioxide can not only mitigate the greenhouse effect, but also utilize the hydrogen generated by renewable electricity such as wind, solar, tidal energy, and others, which could ameliorate the energy crisis to some extent. Highly efficient catalysts and processes are important to make CO2 methanation practical. Although noble metal catalysts exhibit higher catalytic activity and CH4 selectivity at low temperature, their large-scale industrial applications are limited by the high costs. Ni-based catalysts have attracted extensive attention due to their high activity, low cost, and abundance. At the same time, it is of great importance to study the mechanism of CO2 methanation on Ni-based catalysts in designing high-activity and stability catalysts. Herein, the present review focused on the recent progress of CO2 methanation and the key parameters of catalysts including the essential nature of nickel active sites, supports, promoters, and preparation methods, and elucidated the reaction mechanism on Ni-based catalysts. The design and preparation of catalysts with high activity and stability at low temperature as well as the investigation of the reaction mechanism are important areas that deserve further study